PUBLIC COMPANY
saveArthrosi Therapeutics Inc
updated 21d ago
community read0 votes
pipeline
1
marketed
0
phase 3
1
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase2Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients
- phase3Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
- phase3Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)
- phase2Phase 2 to Assess Efficacy and Safety in AR882 Alone or in Combination With Allopurinol in Patients With Tophaceous Gout
🐶 Hiring Signal
News
- With China rising, Hong Kong builds bridge to biotech innovationMassachusetts-based biotech accelerator LabCentral signed an agreement with Hong Kong Science and Technology Parks Corporation in June to connect founders with the U.S. ecosystem—and fuel more inno…biospace · 1d ago
comments(0)
5-min edit window · permanent after that